SCHEMBL1015774

SCHEMBL1015774

COC(=O)c1cc(Cl)ccc1NC(=O)C(=O)Nc1cc(-c2ccc(F)cc2)ccc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
LMNA P02545 2/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
RXFP1 Q9HBX9 2/20 0.43
MAPT P10636 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 3/20 0.40
NOX1 Q9Y5S8 1/20 0.40
MEN1 O00255 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
THRB P10828 1/20 0.40
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016283 0.88 KDM4E (0.52) ALDH1A1RXFP1MAPTTDP1
SCHEMBL1015634 0.88 ALDH1A1 (0.53) ALDH1A1LMNARXFP1MAPTTDP1
SCHEMBL1015128 0.87 KDM4E (0.51) ALDH1A1RXFP1MAPTTDP1
SCHEMBL1015129 0.86 MAPT (0.42) LMNARXFP1MAPTTDP1HTT
SCHEMBL1016922 0.80 ALDH1A1 (0.43) ALDH1A1LMNASLC6A4SLC6A3RXFP1
SCHEMBL1015626 0.78 RXFP1 (0.53) ALDH1A1LMNARXFP1MAPTTDP1
SCHEMBL7037291 0.78 PPARG (0.52) ALDH1A1LMNAMAPTHTTKMT2A
SCHEMBL1014695 0.78 ALDH1A1 (0.53) ALDH1A1LMNARXFP1MAPTTDP1
SCHEMBL1013557 0.76 ALDH1A1 (0.54) ALDH1A1LMNARXFP1MAPTSMN1; SMN2
SCHEMBL1015866 0.76 ALDH1A1 (0.51) ALDH1A1LMNARXFP1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 ALDH1A1 888/4885LMNA 525/4885SLC6A4 4832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.